OUTLOOK THERAPEUTICS, INC./JASON HOPE SCHEDULE 13G

Company

Outlook Therapeutics, Inc.

Filed

April 1, 2022

Accession Number

0001199835-22-000188

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →